T 2116/22 (Process for making hemostatic compositions/BAXTER) of 18.12.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T211622.20241218
- Date of decision
- 18 December 2024
- Case number
- T 2116/22
- Petition for review of
- -
- Application number
- 11724603.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on Article 084 EPC
- Application title
- PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS
- Applicant name
- Baxter International Inc
Baxter Healthcare SA - Opponent name
- Ferrosan Medical Devices A/S
Ethicon Inc. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84European Patent Convention R 106Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Novelty - main request and auxiliary requests 1-7 (no)
Novelty - auxiliary request 8 (yes)
Stay of the proceedings (no)
Obligation to raise objections - objection dismissed
Late-filed request - auxiliary request 8
Late-filed request - admitted (yes)
Amendments - auxiliary request 8
Amendments - allowable (yes)
Claims - clarity
Claims - auxiliary request 8 (yes)
Inventive step - auxiliary request 8 (yes) - Catchword
- -
- Citing cases
- T 2263/22
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of auxiliary request 8 filed on 31 March 2023 and a description to be adapted thereto if necessary.
The objection under Rule 106 EPC is dismissed.